{"id":"W4237312607","doi":"10.2165/00128413-200514930-00064","title":"Health Canada has approved a new indication for candesartan cilexetil","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Candesartan; Medicine; Pharmacy; Intensive care medicine; Family medicine; Internal medicine; Angiotensin II; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00154212,0.0004181923,0.0009709306,0.001448057,0.001861433,0.002598938,0.0009872076,0.002711745,0.02217089],"category_scores_gemma":[0.004703006,0.0003055295,0.001208353,0.001072332,0.0009190395,0.0004081001,0.0005780821,0.005391708,0.004795904],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008160462,"about_ca_system_score_gemma":0.0338509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2566982,"about_ca_topic_score_gemma":0.5429542,"domain_scores_codex":[0.9982252,0.0001542399,0.00009836378,0.0001204418,0.0009716808,0.0004300186],"domain_scores_gemma":[0.9918438,0.001602789,0.000498996,0.0002023613,0.002496384,0.003355818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002378174,0.0009064556,0.01413914,0.0003657192,0.0001320576,0.001323785,0.0000963092,0.0001435419,0.004913231,0.002699758,0.7433354,0.2295664],"study_design_scores_gemma":[0.001812811,0.0008754549,0.04170643,0.0002792183,0.0002735163,0.001113175,0.0001080279,0.0006939693,0.002098794,0.0005470506,0.9504149,0.00007664347],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"editorial","genre_scores_codex":[0.08439264,0.05326143,0.006655381,0.264519,0.03035199,0.001308769,0.0114308,0.003507991,0.544572],"genre_scores_gemma":[0.3046022,0.02904902,0.01799355,0.1775842,0.01761615,0.0003945589,0.01475725,0.0006274364,0.4373758],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.9918395,"threshold_uncertainty_score":0.510408,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03292257216751831,"score_gpt":0.2989812046243451,"score_spread":0.2660586324568268,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}